Form 4: UAMY Director Plans Future Stock Sale

Michael A. McManus Jr., a director and 10% owner of United States Antimony Corp, reported a planned sale of 50,000 shares of common stock under a Rule 10b5-1 plan.

Summary

• Michael A. McManus Jr., a Director and 10% Owner of United States Antimony Corp (UAMY), reported a transaction under a Rule 10b5-1 plan.
• The transaction involves the planned disposition of 50,000 shares of UAMY common stock on October 1, 2025.
• The shares are to be sold at a price of $7.316 per share.
• Following this planned transaction, Mr. McManus will directly beneficially own 531,965 shares of common stock.

Sentiment

Score: 5

Explanation: The reported transaction is a planned disposition of shares under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than a reaction to immediate company news. While it reduces insider ownership, the pre-planned nature mitigates the negative signal typically associated with insider sales, leading to a neutral to slightly cautious sentiment.

Negatives

• The planned disposition of 50,000 shares by a director and 10% owner, while under a Rule 10b5-1 plan, still represents a reduction in insider ownership, which some investors might view with caution.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders might observe a reduction in insider ownership, but the pre-planned nature under a Rule 10b5-1 plan suggests it is not based on new, non-public information, potentially mitigating negative sentiment.

Key Dates

Recommendation

The reported sale by a director and 10% owner is part of a pre-arranged Rule 10b5-1 plan, which suggests the transaction is for personal financial planning rather than a reaction to current company performance. This mitigates the negative signal often associated with insider sales. Investors should maintain a 'hold' position and focus on the company's fundamental performance rather than this specific insider transaction.

Keywords

United States Antimony Corp, UAMY, Michael A McManus Jr, Insider Transaction, Form 4, Director Sale, 10b5-1 Plan, Common Stock